---

---

sector : Professional, scientific, and technical services    tags : Approval   

save search

---

Panbela Therapeutics Announces US WorldMeds NDA Approval for Eflornithine (DFMO) in Pediatric Neuroblastoma
Published: 2023-12-18 (Crawled : 13:00) - globenewswire.com
PBLA | $0.525 -6.31% 38K |

Professional, Scientific, and T...

| -94.31% | O: 29.1% H: 177.92% C: 71.16%
approval therapeutics

---

Endonovo's SofPulse® Secures Taiwan FDA Approval
Published: 2023-10-12 (Crawled : 13:00) - globenewswire.com
ENDV | $0.0032 158.07% 280K |

Professional, Scientific, and T...

| -68.0% | O: 22.0% H: 0.0% C: -11.48%
sofpulse fda approval

---

Gain Therapeutics Receives Approval to Commence Phase 1 Clinical Study of GT-02287 from the Human Research Ethics Committee (HREC) in Australia
Published: 2023-09-12 (Crawled : 13:30) - globenewswire.com
GANX | $3.14 -0.63% -0.64% 81K |

Professional, Scientific, and T...

| -13.11% | O: 4.37% H: 2.98% C: -4.71%
gt-0228 australia approval research therapeutics study

---

BriaCell Receives Court Approval for the Share Arrangement Spinning Out BriaPro Therapeutics (SpinCo) to Existing Shareholders
Published: 2023-08-25 (Crawled : 19:00) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K |

Professional, Scientific, and T...

| Email alert Add to watchlist
approval therapeutics

---

LianBio Partner Tarsus Pharmaceuticals Announces U.S. FDA Approval of XDEMVY™ (lotilaner ophthalmic solution) 0.25% for the Treatment of Demodex Blepharitis
Published: 2023-07-26 (Crawled : 12:00) - globenewswire.com
LIAN | $4.92 0.41% 0.41% 410K |

Professional, Scientific, and T...

| 144.5% | O: 5.0% H: 4.29% C: -2.38%
fda approval treatment pharmaceuticals

---

ACG Acquisition notes Brazil antitrust approval for mines acquisition – Morningstar
Published: 2023-07-06 (Crawled : 13:00) - spacfeed.com
EFSH 4 | $1.87 -19.74% 1.6% 230K |

Professional, Scientific, and T...

| -90.31% | O: -0.62% H: 0.0% C: -7.7%
approval acquisition brazil

---

ACG Acquisition notes Brazil antitrust approval for mines acquisition – Marketscreener.com
Published: 2023-07-06 (Crawled : 12:00) - spacfeed.com
EFSH 4 | $1.87 -19.74% 1.6% 230K |

Professional, Scientific, and T...

| -90.31% | O: -0.62% H: 0.0% C: -7.7%
approval acquisition brazil

---

LianBio Announces Marketing Approval of CAMZYOS® (mavacamten) in Singapore
Published: 2023-06-26 (Crawled : 12:00) - globenewswire.com
LIAN | $4.92 0.41% 0.41% 410K |

Professional, Scientific, and T...

| 102.9% | O: 1.66% H: 1.91% C: -9.39%
camzyos approval

---

LianBio Announces Marketing Approval of CAMZYOS® (mavacamten) in the Macau Special Administrative Region (SAR) of China
Published: 2023-05-11 (Crawled : 11:00) - globenewswire.com
LIAN | $4.92 0.41% 0.41% 410K |

Professional, Scientific, and T...

| 124.31% | O: 0.0% H: 10.09% C: 0.92%
camzyos approval china

---

TransCode Therapeutics Announces IRB Approval for FDA Cleared First-In-Human Clinical Trial
Published: 2023-04-27 (Crawled : 11:00) - globenewswire.com
RNAZ | $0.5 -0.99% -1.0% 280K |

Professional, Scientific, and T...

| -93.24% | O: 16.22% H: 3.49% C: -22.26%
fda cleared approval trial therapeutics

---

Dominari Financial Granted Approval to Acquire Broker Dealer
Published: 2023-03-21 (Crawled : 21:00) - prnewswire.com
DOMH | $2.88 3.6% 3.47% 3.1K |

Professional, Scientific, and T...

| -14.98% | O: -1.53% H: 4.35% C: -7.45%
granted approval acquire financial

---

Healthcare Integrated Technologies, Inc. Announces Approval of U.S. Patent for Fall Validation with Privacy-Aware Monitoring System
Published: 2023-03-17 (Crawled : 14:00) - globenewswire.com
HITC | $0.09 70.77% 17K |

Professional, Scientific, and T...

| -33.33% | O: 3.27% H: 5.23% C: 2.0%
patent approval system

---

BioRestorative Therapies to Seek FDA Approval to Expand the Clinical Application of BRTX-100
Published: 2023-03-13 (Crawled : 12:00) - biospace.com/
BRTX | $1.37 4.58% 4.38% 660K |

Professional, Scientific, and T...

| -56.62% | O: -2.65% H: 5.44% C: 5.44%
brtx-100 fda application approval

---

Bioxytran Receives Approval to Initiate Trials with ProLectin-I
Published: 2023-02-06 (Crawled : 16:00) - biospace.com/
BIXT | $0.117 490.75% 140K |

Professional, Scientific, and T...

| -75.88% | O: 0.0% H: 3.09% C: -2.06%
trials approval

---

GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidate
Published: 2023-02-01 (Crawled : 14:00) - biospace.com/
GRNA | $0.2995 -0.03% -0.07% 0 |

Professional, Scientific, and T...

| -72.52% | O: 6.24% H: 0.0% C: -5.87%
covid-19 candidate vaccine mrna trial approval

---

Bioxytran Receives Approval to Optimize Dosage in COVID-19 Patients
Published: 2022-12-08 (Crawled : 13:20) - biospace.com/
BIXT | $0.117 490.75% 140K |

Professional, Scientific, and T...

| -71.49% | O: 4.78% H: 0.0% C: 0.0%
covid-19 approval

---

1847 Holdings Announces NYSE American Listing Approval
Published: 2022-04-27 (Crawled : 17:00) - globenewswire.com
EFSH 4 | $1.87 -19.74% 1.6% 230K |

Professional, Scientific, and T...

| -4.9% | O: 0.0% H: 83.67% C: 38.78%
approval

---

BriaCell Receives FDA Fast Track Approval for Targeted Breast Cancer Immunotherapy
Published: 2022-04-13 (Crawled : 17:00) - biospace.com/
BCTX | $2.19 -5.6% -5.94% 140K |

Professional, Scientific, and T...

| -72.15% | O: 11.0% H: 2.27% C: -17.91%
fda immunotherapy approval cancer breast cancer

---

Impel NeuroPharma Announces U.S. FDA Approval of TRUDHESA™ (Dihydroergotamine Mesylate) Nasal Spray for the Acute Treatment of Migraine
Published: 2021-09-03 (Crawled : 13:00) - globenewswire.com
IMPL 4 | $0.2411 -77.19% 860K |

Professional, Scientific, and T...

| -98.21% | O: 46.24% H: 2.78% C: -44.84%
nasal spray treatment fda migraine fda approval approval

---

Synaptogenix Responds to FDA Approval of Aducanumab
Published: 2021-06-07 (Crawled : 16:00) - prnewswire.com
SNPX | $4.73 1.72% 1.69% 120K |

Professional, Scientific, and T...

| -31.03% | O: 7.76% H: 26.67% C: -8.67%
fda fda approval approval

---

Gainers vs Losers

56%

44%

Top 10 Gainers

INVO | $1.76 131.58% 56.82% 230M |

Health Technology

SINT | $0.0365 59.39% 37.26% 470M |

Health Technology

WISA 4 | $9.19 50.66% 33.7% 65M |

Electronic Technology

EDBL | News | $6.73 47.91% 32.39% 13M |

GCTK | $0.715 36.27% 26.62% 640K |

Manufacturing

TCON | $2.33 36.26% 26.61% 2M |

Health Technology

TIRX | $0.48 6.43% 24.58% 4.8M |

KZIA | $0.38 30.58% 23.42% 300K |

Health Technology

VNDA | News | $5.23 29.14% 22.56% 24M |

Health Technology

ATNF | $1.91 29.05% 22.51% 310K |

---

Your saved searches

---